companies / contraline-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-06-13 json
| total_raised | 55,804,74155.8M | D |
|---|---|---|
| founded | null | |
| hq | CHARLOTTESVILLE, VA | |
| industry | unknown | |
| stage | null |
Contraline develops investigational male contraceptives, including a daily topical gel that pauses sperm production and ADAM, a long-acting, non-hormonal, reversible implant. It serves men and couples sharing contraceptive responsibility. Its edge is bringing reversible male contraception to a market little changed beyond condoms and vasectomy.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-06-10 | Funding round | 55,804,74155.8M | null | D |
| 2021-03-02 | Funding round | 7,225,6697.2M | null | D |
| person | role | src |
|---|---|---|
| Gurdane Bhutani | director | D |
| Iris Van Alderwerelt van Rosenburgh | director | D |
| Kevin Eisenfrats | director | D |
| Kevin Eisenfrats | executive | D |
| Kevin Eisenfrats | promoter | D |
| Kevin S Eisenfrats | director | D |
| Kevin S Eisenfrats | executive | D |
contentful, hsts, react, vercel
| fact | status | src |
|---|---|---|
| Funding round, $55.8M | sourced | D |
| Funding round, $7.2M | sourced | D |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-25latest_round: seed, $55.8M, 2026-06-10 → Funding round, $55.8M, 2026-06-10, D 2026-09-25 | latest_round | seed, $55.8M, 2026-06-10 → Funding round, $55.8M, 2026-06-10 | D 2026-09-25 |
| 2026-09-25provenance_round: attributed → sourced, D 2026-09-25 | provenance_round | attributed → sourced | D 2026-09-25 |
Records begin 2026-09-24. all_changes
| Kevin S Eisenfrats | promoter | D |
| Martin Emerson | director | D |
| Martin J Emerson | director | D |
| Michael King | director | D |
| Tom Thorpe | director | D |